LM
LMAT
Market ClosedLeMaitre Vascular, Inc.
US
651 employees
CEO: George W. LeMaitre
Founded: 2006
$85.33
+$0.00(+NaN%)
Market Cap
1.95B
Beta
0.47
52W Range
N/A
Dividend Yield
1.11%
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
71.5%
18.3%
CAGR: 15.2%
Profit after direct costs
Operating Margin
27.2%
30.0%
CAGR: 16.9%
Core business profitability
Net Margin
23.1%
31.1%
CAGR: 21.0%
Bottom line profitability
Revenue Growth
13.5%
YoY
CAGR: 12.8%
Top line growth rate
Revenue Flow Analysis
Visual flow showing how LMAT allocates revenue across expenses and profit
Fiscal Year 2025
Revenue Distribution
Flow of revenue through cost categories to net income
Gross Margin
71.5%
$178.54M
Operating Margin
27.2%
$67.91M
Net Margin
23.1%
$57.73M
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 154.42M | 161.65M | 193.48M | 219.86M | 249.60M | 13.5% | |
| Cost of Revenue | (53.04M) | (56.76M) | (66.44M) | (68.96M) | (71.06M) | 3.0% | |
Gross Profit | 101.38M | 104.90M | 127.05M | 150.90M | 178.54M | 18.3% | |
| Operating Expenses | |||||||
| Research & Development | (11.80M) | (13.29M) | (16.97M) | (15.65M) | (14.14M) | -9.7% | |
| Selling, General & Administrative | (53.16M) | (61.67M) | (72.89M) | (83.00M) | (96.49M) | 16.3% | |
| General & Administrative | (25.50M) | (28.75M) | (31.83M) | (36.26M) | (42.02M) | 15.9% | |
| Selling & Marketing | (27.66M) | (32.92M) | (41.05M) | (46.74M) | (54.46M) | 16.5% | |
| Depreciation & Amortization | (9.47M) | (9.43M) | (9.52M) | (9.67M) | (10.42M) | 7.7% | |
Operating Income (EBIT) | 36.42M | 26.83M | 36.71M | 52.26M | 67.91M | 30.0% | |
| Non-Operating Items | |||||||
| Interest Income | 197.00K | 986.00K | 3.08M | 4.95M | 13.09M | 164.6% | |
| Interest Expense | (2.22M) | — | — | (205.00K) | (5.18M) | 2428.8% | |
| Other Income/Expenses (Net) | -2.14M | 661.00K | 2.76M | 4.62M | 7.27M | 57.4% | |
Income Before Tax | 34.29M | 27.49M | 39.48M | 56.88M | 75.18M | 32.2% | |
| Income Tax Expense | (7.38M) | (6.85M) | (9.37M) | (12.84M) | (17.45M) | 35.9% | |
Net Income | 26.91M | 20.64M | 30.11M | 44.04M | 57.73M | 31.1% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $1 | $1 | $2 | $3 | 30.1% | |
| Weighted Avg Shares Outstanding | 21.16M | 21.98M | 22.22M | 22.45M | 22.64M | 0.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 21.48M | 22.17M | 22.42M | 22.78M | 22.93M | 0.7% | |
EBITDA | 45.98M | 36.92M | 48.99M | 66.75M | 90.79M | 36.0% |
Explore LMAT
LMAT in the Healthcare
Small Cap